Dr. Yassine Bendiabdallah - Chief Operating Officer, Director at Pasithea Therapeutics Corp.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Operating Officer, Director
Issuer Symbol
KTTA, KTTAW on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Dr. Yassine Bendiabdallah since 12 Mar 2025

Holdings reported by Dr. Yassine Bendiabdallah for Pasithea Therapeutics Corp.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 300,000 $129,300 $0.4310 14 Sep 2021 Direct

There are no transactions reported by Dr. Yassine Bendiabdallah for Pasithea Therapeutics Corp.